Alphabet’s AI-driven Google Cloud has transformed from a loss-making unit into a high-margin, cash-generating growth engine.

Fintel reports that on January 5, 2026, Citizens upgraded their outlook for Ironwood Pharmaceuticals (NasdaqGS:IRWD) from ...

As of Monday, January 05, Ironwood Pharmaceuticals, Inc.’s IRWD share price has surged by 15.93%, which has investors ...

Ironwood Pharmaceuticals advances GI-focused medicines as Nasdaq futures discussions track broader biotech activity.

Chip designer MediaTek is realigning priorities by diverting its engineering and research muscle toward AI-focused custom ...

Alphabet's AI momentum in Search and Cloud gives it an edge, while Adobe faces rising competition despite solid growth ...

Per Synergy Research Group data, Amazon’s share in the worldwide cloud infrastructure market amounted to 29% in the third ...

Ironwood Pharmaceuticals remains undervalued despite a failed $1bn Vectiv Bio acquisition and subsequent stock plunge, with Linzess providing strong recurring revenue. IRWD's apraglutide Phase 3 trial ...

Ironwood Pharmaceuticals, Inc. recently reported third quarter earnings, revealing revenue of US$122.06 million and net income of US$40.08 million, both up substantially from the prior year, and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Ironwood Pharmaceuticals is in ...

Google launches Ironwood, its most powerful AI chip yet, delivering fourfold performance gains to challenge Nvidia and redefine AI infrastructure. In a major leap for artificial intelligence ...